Objective: Autologous HIV-1-infected CD4 þ primary T cells (aHIV þ CD4) have been shown to be largely resistant to natural killer (NK)-cell-mediated lysis because of viral strategies of immune evasion. We have previously shown that a preactivation of NK cells with plasmacytoid dendritic cells can significantly augment lysis of aHIV þ CD4 through a mechanism dependent on interferon-alpha (IFN-a).
Introduction
The ability of NK cells to discriminate between normal and abnormal cells involves complex interactions MHC-class-I (MHC-I) molecules induces negative regulatory signals that switch off NK cells [6] [7] [8] [9] [10] [11] . Heterologous target cells expressing iNKR-mismatched MHC-I proteins exhibit a naturally increased target cell sensitivity to NK cell lysis. In contrast, normally resistant autologous target cells become susceptible to NK cell cytotoxicity during viral infection or tumor transformation when MHC-I proteins are downregulated. Following the reduction of inhibitory signals, NK cells then require the engagement of aNKRs to induce the killing of susceptible target cells. Examples of aNKRs include: the NKG2D receptor that recognizes stress-induced ligands [12] [13] [14] [15] , the Fc-gIII receptor (CD16), which mediates antibody-dependent cytotoxicity [16] [17] [18] , activating KIRs lacking inhibitory motifs [19] [20] [21] and the Natural Cytotoxicity Receptor Family (NKp46, NKp30, NKp44), which directly recognizes viral or cellular antigens [22] [23] [24] [25] [26] [27] . NK cell effector functions are also modulated by co-stimulatory receptors such as 2B4 or NTBA that can synergize with other aNKRs to induce higher levels of cellular lysis [28, 29] . Likewise, cytokines such as interleukin-2, interleukin-12, interleukin-15, interleukin-21 or interferon-alpha (IFN-a) can also augment lysis of susceptible targets cells by preactivating NK cells [30] [31] [32] [33] [34] [35] [36] [37] [38] .
The autologous HIV-1-infected CD4 þ primary T-cell (aHIV þ CD4) NK assay system represents the most physiologically relevant in-vitro model for measuring NK activity because of the complete match between MHC-I alleles on HIV þ CD4 target cells and iNKRs on NK cells [39] [40] [41] . However, aHIV þ CD4 have been shown to be largely resistant to lysis by NK cells in vitro because of viral strategies of immune evasion [39, 42, 43] . We have previously shown that NK cytotoxicity against aHIV þ CD4 can be significantly augmented by plasmacytoid dendritic cell (pDC) activation of NK cells through an IFN-a-dependent mechanism [44] . We have also observed that purified pDCs alone are sufficient to recognize aHIV þ CD4 and secrete high amounts of IFNa that in turn can activate NK cells [45] . However, the specific receptors utilized by NK cells during IFN-aactivated lysis of autologous HIV þ CD4 remains undetermined. Using a modified version of our aHIV þ CD4/ pDC recognition system, we now investigated the specific aNKRs involved in lysis of aHIV þ CD4 following activation of NK cells with endogenous levels of IFN-a.
Materials and methods

HIV-1 infection
Peripheral blood mononuclear cells (PBMCs) were isolated from 20 healthy uninfected donors according to informed consent and Institutional Review Board approval from The Wistar Institute. PBMCs were stimulated for 3 days with 10 mg/ml PHA-p (Sigma Aldrich, St Louis, Missouri, USA) and 100 IU/ml hIL-2 (PeproTech, Rocky Hill, New Jersey, USA). CD4 þ primary T cells were isolated by positive selection using anti-CD4 magnetic beads as described by the manufacturer (Miltenyi Corporation, San Diego, California, USA). A total of 5 Â 10 6 activated CD4 þ T cells were spinfected with 150 ng of p24 containing supernatant of the CXCR4-tropic HIV-1 isolate TYBE as previously described [44] . After 4 days of infection, we enriched HIV-1-infected cells that downregulated the CD4 receptor during infection (X >70% infectivity per donor) by removing uninfected CD4 þ T cells using anti-CD4 depletion magnetic beads (Miltenyi) as previously described [39] .
Flow cytometry
The following antibodies were used at the recommended dilution of 0.25 mg antibody/million cells: CD3 (SK7), CD4 (SK3), CD16 (3GB), CD56 (B159), CD69 (FN50). Cell surface staining for CD69 activation was carried on CD56 þ /CD3gated NK cells with gates set upon unstimulated control cells. For intracellular staining of the HIV-1 p24 gag protein, CD4 þ T cells were permeabilized with the Cytofix/Cytoperm kit (BD Biosciences, San Jose, California, USA) as described by the manufacturer and stained with the antip24 KC57 FITC antibody (Beckman Coulter, Pasadena, California, USA). Samples were collected on a LSRII Cytometer (BD) and were analyzed with FlowJo software (Tree Star Incorporated, Ashland, Oregon, USA).
NK chromium 51 release cytotoxicity assay
HIV-1-infected or uninfected CD4 þ primary T cells were generated over a 7-day period as described above and incubated with autologous PBMC isolated from a second blood draw at a 25 : 1 PBMC:CD4 ratio for 18 h as depicted in Fig. 1 , panel A. Following overnight incubation, NK cells were tested for upregulation of the CD69 activation marker by flow cytometry and IFN-a secretion into the supernatant was measured by IFN alpha-2a ELISA (PBL Biomedical Laboratories, Piscataway, New Jersey, USA) as described previously [44] . On the day of chromium lysis assay, a second aliquot of HIV-1-infected CD4 þ primary T cells was labeled with 100 mCu Na 2 51 CrO 4 for 3 h and incubated with autologous PBMC effector cells (containing activated NK cells as described above) at a 100 : 1 PBMC/CD4 ratio in a 4-h chromium lysis assay as described previously [44] . Saturating concentrations of specific monoclonal antibodies (mAbs) were added to the PBMC cultures for masking experiments utilizing a one-fourth total volume of antibody per well (50 ml in a 200 ml total volume). The following masking antibodies (mAbs) kindly provided by Prof. Alessandro Moretta were used for the study: BAT221 (IgG1, anti NKG2D), BAB-281 (IgG1, anti-NKp46), F252 (IgM, anti NKp30), KS38 (IgM, anti-NKp44), KL247 (IgM, anti-NKp46), CO54 (IgM, anti2B4), ON56 (IgG2a, anti-NTBA), and FS280 (IgG2a, anti-CD56). The appropriate IgG1 or IgM blocking antibody for NKp46 was chosen for blocking experiments when compared with NKG2D (IgG1) and NKp30/NKp44 (IgM), whereas anti-CD56 was used as a control antibody.
Statistical analysis
All graphic presentations and statistical analysis were performed with Prism software (GraphPad Software, La Jolla, California, USA). In individual representative experiments, error bars depict the standard deviation. In composite graphs of multiple experiments, cross bars represent the median. Statistical analysis of three groups was carried out using a Friedman matched pair, nonparametric ANOVA test with a posthoc Dunn analysis. P values were two-sided with alphas noted in figures by asterisks as follows: P < 0.05 ( Ã ), P < 0.01 ( ÃÃ ) or P < 0.001 ( ÃÃÃ ). 
Results
Direct recognition of aHIV þ CD4 induces the secretion of IFN-a, that in turn leads to NK cell activation and triggers cytotoxicity against aHIV þ CD4 through NKp46 and NKG2D.
To investigate the specific NK-activating receptors involved in IFN-a-activated NK lysis of HIV-1-infected autologous CD4 þ primary T cells (aHIV þ CD4), we utilized a modified version of our previously published autologous experimental approach [45] . As shown in Fig. 1, this model system involves the incubation of PBMC for 18 h with aHIV þ CD4 to induce the secretion of IFN-a (median 2280 pg/ml, P < 0.001, n ¼ 9) that in turn stimulates NK activation (P < 0.001, n ¼ 12) and significantly increases the NK cytolytic potential against aHIV þ CD4 (P < 0.01, n ¼ 12). We have previously determined that depletion of pDCs from PBMC prior to incubation with aHIV þ CD4 abrogated the secretion of IFN-a and NK cell activation [45] . We have also shown that depletion of NK cells from IFN-a-stimulated PBMCs reduced lysis of aHIV þ CD4 to undetectable levels and that lysis of aHIV þ CD4 can be recapitulated with purified NK cells incubated solely with IFN-a [44] . We next performed masking experiments with a panel of monoclonal antibodies (mAbs) specific for different NK-activating receptors to identify the NK cell receptor pathways regulating IFN-a-activated lysis of aHIV þ CD4. As shown in two representative experiments ( Fig. 2a and b ) and across multiple donors (Fig. 2c) , the masking of either NKp46 or NKG2D significantly reduced the IFN-a activated lysis of aHIV þ CD4 (P < 0.01 and P < 0.05, n ¼ 8). In contrast, the blocking of the co-stimulatory receptors NTBA and 2B4 ( Fig. 2a ) or natural cytotoxicity receptors NKp30 and NKp44 (Fig. 2b ) did not alter IFN-a-activated lysis of aHIV þ CD4. Taken together, these results demonstrate that endogenous levels of IFN-a secreted by pDCs in response to HIV-1-infected target cells induce NK cells to lyse aHIV þ CD4 via the engagement of NKp46 and NKG2D.
Discussion
Utilizing a physiologically relevant model system for measuring NK lysis, we demonstrate here that endogenous levels of IFN-a secreted by pDCs induce NK cells to lyse aHIV þ CD4 via the engagement of NKp46 and NKG2D (but not 2B4, NTBA, NKp30 or NKp44). Our results showing a key role of NKG2D in triggering the NK cell-mediated clearance of aHIV þ CD4 are in line with previous studies reporting the up-regulation of NKG2D ligands on the surface of HIV-1-infected cells [40, 41] . We now extend this finding by demonstrating that the NKp46 receptor is also required for lysis of aHIV þ CD4 following IFN-a activation. As both cellular and viral antigens can act as ligands for the NKp46 receptor, an exploratory proteomic approach may be needed to discover the ligand induced on aHIV þ CD4 in future studies.
Of note, previous studies have also shown a role for NKp44 in NK recognition of HIV-1-infected target cells from HIV-1-infected viremic subjects [27] . In our experimental approach, we could not detect any contribution of NKp44 in the clearance of aHIV þ CD4 CD4 following IFN-a activation. This finding is not unexpected, as NKp44 is not expressed on resting NK cells [4, 16, 23, 27, 29, 41, 46, 47] . Rather, NKp44 is upregulated during chronic HIV-1 viral infection or following stimulation of NK cells with certain cytokines such as interleukin-2 (but not IFN-a) [25, 27, 29, 46, 48] .
Similarly, it has been previously reported that the blocking of NKG2D, but not NKp46, reduces NK lysis of aHIV þ CD4 [41] . The discrepancy between this study and our results may be related to the absence of IFN-a stimulation and testing lysis of whole NK populations versus selected NK subsets as effectors. Previously, Ward et al. utilized depleted NK cell cultures wherein NK cells-expressing inhibitory receptors were removed to stimulate NK lysis [41] . Here, we utilized endogenous IFN-a activation of total NK cell populations to overcome the immune evasion mechanisms of HIV-1. It remains to be determined whether IFN-a selectively activates lysis of aHIV þ CD4 by NK cells expressing inhibitory receptors that have been licensed to kill during ontogeny. The implications of our data to HIV-1-infected subjects pertain to retained NK function during viral control, as prolonged viremia is associated with NK dysfunction. Specifically, during ART immune reconstitution, we would expect a recovery of IFN-a-stimulated NK lytic activity against HIV-1-infected autologous CD4 þ primary T cells by the same mechanism as described here for NKp46 and NKG2D (and potentially NKp44). Future longitudinal studies addressing ART, the degree of CD4 reconstitution and NK/pDC functional recovery will be needed to determine the timeline to NK cell responses against autologous infected targets following ART suppression.
Taken together, our results demonstrate that pDC driven NK activation through IFN-a stimulates lysis of aHIV þ CD4 through a mechanism dependent on NKp46 and NKG2D. Having established the anti-HIV activity of IFN-a2 as an immunotherapy in antiretroviral therapy suppressed subjects [49] , and a role for pDC frequency and control of viral replication [50, 51] , our results here further highlight innate immunity and pDC/NK crosstalk in control over HIV-1. Conversely, the reduction in pDC function and NKp46 receptor expression during viremia [46, [52] [53] [54] suggests that a loss of IFN-a-activated NK recognition of HIV-1 infected target cells through NKp46 may contribute to higher HIV-1 replication and disease progression.
